TEVA PHARMACEUTICAL INDUSTRIES LIMITED Deferred Income Tax Expense (Benefit)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Deferred Income Tax Expense (Benefit) of -$418.00 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2025-02-05
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED deferred income tax expense (benefit) for the quarter ending 2010-12-31 was -$198.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED deferred income tax expense (benefit) for the quarter ending 2010-09-30 was -$85.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED deferred income tax expense (benefit) for the quarter ending 2010-06-30 was $6.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED deferred income tax expense (benefit) for the quarter ending 2010-03-31 was $0.00.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED deferred income tax expense (benefit) for fiscal 2024 was -$418.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED deferred income tax expense (benefit) for fiscal 2023 was -$340.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED deferred income tax expense (benefit) for fiscal 2022 was -$1.07B.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED deferred income tax expense (benefit) for fiscal 2021 was -$59.00M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 3 month as first filed | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 6 month as first filed | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | -$418.00M 10-K · filed 2025-02-05 | ||||||
| 2023-12-31 | -$340.00M 10-K · filed 2025-02-05 | ||||||
| 2022-12-31 | -$1.07B 10-K · filed 2025-02-05 | -$1.07B 10-K · filed 2023-02-10 | |||||
| 2021-12-31 | -$59.00M 10-K · filed 2024-02-12 | ||||||
| 2020-12-31 | -$350.00M 10-K · filed 2023-02-10 | ||||||
| 2019-12-31 | -$1.16B 10-K · filed 2022-02-09 | ||||||
| 2018-12-31 | -$895.00M 10-K · filed 2021-02-10 | ||||||
| 2017-12-31 | -$2.31B 10-K · filed 2020-02-21 | ||||||
| 2016-12-31 | $40.00M 10-K · filed 2019-02-19 | ||||||
| 2015-12-31 | $336.00M 10-K · filed 2018-02-12 | ||||||
| 2014-12-31 | -$288.00M 20-F · filed 2017-02-15 | ||||||
| 2013-12-31 | -$1.14B 20-F · filed 2016-02-11 | ||||||
| 2012-12-31 | -$701.00M 20-F · filed 2015-02-09 | ||||||
| 2011-12-31 | -$562.00M 20-F · filed 2014-02-10 | ||||||
| 2010-12-31 | -$198.00M derived: 20-F 12 month − 6-K 9 month · filed 2013-02-12 | -$283.00M derived: sum of 2 quarters · filed 2013-02-12 | -$277.00M derived: sum of 3 quarters · filed 2013-02-12 | -$277.00M 20-F · filed 2013-02-12 | |||
| 2010-09-30 | -$85.00M derived: 6-K 9 month − 6-K 6 month · filed 2010-11-02 | -$79.00M derived: sum of 2 quarters · filed 2010-11-02 | -$79.00M 6-K · filed 2010-11-02 | -$190.00M derived: sum of 4 quarters · filed 2012-02-17 | |||
| 2010-06-30 | $6.00M derived: 6-K 6 month − 6-K 3 month · filed 2010-07-27 | $6.00M 6-K · filed 2010-07-27 | -$105.00M derived: sum of 3 quarters · filed 2012-02-17 | -$128.00M derived: sum of 4 quarters · filed 2012-02-17 | |||
| 2010-03-31 | $0.00 6-K · filed 2010-05-04 | -$111.00M derived: sum of 2 quarters · filed 2012-02-17 | -$134.00M derived: sum of 3 quarters · filed 2012-02-17 | -$180.00M derived: sum of 4 quarters · filed 2012-02-17 | |||
| 2009-12-31 | -$111.00M derived: 20-F 12 month − 6-K 9 month · filed 2012-02-17 | -$134.00M derived: sum of 2 quarters · filed 2012-02-17 | -$180.00M derived: sum of 3 quarters · filed 2012-02-17 | -$242.00M 20-F · filed 2012-02-17 | -$140.00M 20-F · filed 2010-02-22 | ||
| 2009-09-30 | -$23.00M derived: 6-K 9 month − 6-K 6 month · filed 2010-11-02 | -$69.00M derived: sum of 2 quarters · filed 2010-11-02 | -$131.00M 6-K · filed 2010-11-02 | -$307.00M derived: sum of 4 quarters · filed 2011-02-15 | |||
| 2009-06-30 | -$46.00M derived: 6-K 6 month − 6-K 3 month · filed 2010-07-27 | -$108.00M 6-K · filed 2010-07-27 | -$137.00M 6-K · filed 2009-07-29 | -$284.00M derived: sum of 3 quarters · filed 2011-02-15 | -$260.00M derived: sum of 4 quarters · filed 2011-02-15 | ||
| 2009-03-31 | -$62.00M 6-K · filed 2010-05-04 | -$79.00M 6-K · filed 2009-05-07 | -$238.00M derived: sum of 2 quarters · filed 2011-02-15 | -$214.00M derived: sum of 3 quarters · filed 2011-02-15 | -$328.00M derived: sum of 4 quarters · filed 2011-02-15 | ||
| 2008-12-31 | -$176.00M derived: 20-F 12 month − 6-K 9 month · filed 2011-02-15 | -$152.00M derived: sum of 2 quarters · filed 2011-02-15 | -$266.00M derived: sum of 3 quarters · filed 2011-02-15 | -$306.00M 20-F · filed 2011-02-15 | $25.00M 20-F · filed 2010-02-22 | ||
| 2008-09-30 | $24.00M derived: 6-K 9 month − 6-K 6 month · filed 2009-11-03 | -$90.00M derived: sum of 2 quarters · filed 2009-11-03 | -$130.00M 6-K · filed 2009-11-03 | ||||
| 2008-06-30 | -$114.00M derived: 6-K 6 month − 6-K 3 month · filed 2009-07-29 | -$154.00M 6-K · filed 2009-07-29 | |||||
| 2008-03-31 | -$40.00M 6-K · filed 2009-05-07 | ||||||
| 2007-12-31 | $100.00M 20-F · filed 2010-02-22 |